Antibody Therapeutics (IF=4.8, Oxford University Press) ⚡ Review Highlight -CAR NK cell therapy for solid tumors: potential and challenges
doi.org/10.1093/abt/...
#mab #mabs #antibody #antibodies #antibodydiscovery #antibodytherapeutics #biologics #naturalkillercells #CAR #CARNK

Antibody Therapeutics (IF=4.8, Oxford University Press) ⚡ Research Highlight - A landscape of sequence variants in 51 commercial antibody therapeutics.
doi.org/10.1093/abt/...
#antibodydiscovery #antibodytherapeutics #biologics #sequencevariant #biosimilar #massspectrometry

Antibody Therapeutics (IF=4.8, Oxford University Press) ⚡ Research Highlight -rAbDesFlow: a novel workflow for computational recombinant antibody design for healthcare engineering.
doi.org/10.1093/abt/...
#antibodydiscovery #biologics #rabdesflow #ca125 #computationalworkflow

Antibody Therapeutics (IF=4.8, Oxford University Press) ⚡ Research Highlight -Preclinical development of mecbotamab vedotin (BA3011), a novel, AXL-specific conditional active biologic antibody–drug conjugate.
doi.org/10.1093/abt/...
#mabs #antibody #antibodies #antibodydiscovery

Antibody Therapeutics (IF=4.8, Oxford University Press) ⚡ Research Highlight -First site-specific conjugation method for native goat IgG antibodies via glycan remodeling at the conserved Fc region.
doi.org/10.1093/abt/...
#mabs #antibody #antibodydiscovery #antibodytherapeutics